Artemis Medicare Services Limited (NSE:ARTEMISMED)
India
· Delayed Price · Currency is INR 267.45
-1.75 (-0.65%)
Jun 6, 2025, 3:29 PM IST
Artemis Medicare Services Revenue
In the fiscal year ending March 31, 2025, Artemis Medicare Services had annual revenue of 9.37B INR with 6.64% growth. Artemis Medicare Services had revenue of 2.40B in the quarter ending March 31, 2025, with 6.51% growth.
Revenue
9.37B
Revenue Growth
+6.64%
P/S Ratio
3.97
Revenue / Employee
4.71M
Employees
1,991
Market Cap
37.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 9.37B | 583.42M | 6.64% |
| Mar 31, 2024 | 8.79B | 1.41B | 19.14% |
| Mar 31, 2023 | 7.37B | 1.83B | 32.92% |
| Mar 31, 2022 | 5.55B | 1.46B | 35.85% |
| Mar 31, 2021 | 4.08B | -1.57B | -27.72% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Artemis Medicare Services News
- 5 months ago - Artemis Medicare Services announces closure of cardiac centre in Chennai - Business Upturn